GLAXOSMITHKLINE PLC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-06 5:26 pm Purchase |
2020-10-29 | 13D | Turning Point Therapeutics, Inc. TPTX |
GLAXOSMITHKLINE PLC | 2,273,618 4.900% |
4,958 (+0.22%) |
Filing |
| 2020-05-26 5:06 pm Purchase |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
GLAXOSMITHKLINE PLC | 2,268,660 5.500% |
276,110 (+13.86%) |
Filing |